Global private equity and venture capital news and research

Venture-backed anti-epilepsy drug developer planning $67m share sale $

26 Nov 2012

brain_lrgVenture capital-backed nervous system disease treatment developer Supernus Pharmaceuticals is planning to raise more than $67m by selling six million shares of common stock.

Sorry, you have reached your quota of 1 free article a week or you are attempting to read a Premium story.

To access the latest news and PREMIUM stories for FREE download the new AltAssets mobile app from the Googe Play or App Store.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015